IL-23 blockade with guselkumab potentially modifies psoriasis pathogenesis: rationale and study protocol of a phase 3b, randomised, double-blind, multicentre study in participants with moderate-to-severe plaque-type psoriasis (GUIDE)
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
BMJ Publishing Group
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/673be33cf2a54e4aba93d38bcb985891 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|